ロード中...
PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation
BACKGROUND: Myocardial ischemia-reperfusion injury (IRI) has become one of the most serious complications after reperfusion therapy in patients with acute myocardial infarction. Small ubiquitin-like modification (SUMOylation) is a reversible process, including SUMO E1-, E2-, and E3-mediated SUMOylat...
保存先:
| 出版年: | BMC Cell Biol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6233564/ https://ncbi.nlm.nih.gov/pubmed/30419807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12860-018-0176-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|